Intellect vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 39)
Intellect logo

Intellect

EmergingHealthcare

Mental Health Benefits

Intellect is a mental health platform providing employer-sponsored coaching, therapy, and wellbeing programs focused on the Asia-Pacific market. HQ: Singapore.

AI VisibilityBeta
Overall Score
D39
Category Rank
#421 of 596
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
43
Perplexity
43
Gemini
41

About

Intellect is a corporate mental health platform providing employers in Asia-Pacific access to mental health coaching, therapy, crisis support, and digital wellbeing programs for their employees. Founded in 2019 in Singapore by Theodoric Chew, the platform addresses the significant mental health challenges in Asian workplaces, where stigma around seeking mental health support has historically been higher than in Western markets but awareness is growing, particularly among younger workforce generations.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

39
Overall Score
90
#421
Category Rank
#2
81
AI Consensus
83
stable
Trend
stable
43
ChatGPT
92
43
Perplexity
93
41
Gemini
89
37
Claude
96
45
Grok
95

Key Details

Category
Mental Health Benefits
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Intellect
Mental Health Benefits

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.